Xeris Biopharma Holdings, Inc. (FRA:2B30)
Germany · Delayed Price · Currency is EUR 5.84
-0.09 (-1.52%)
At close: Jan 7, 2026
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of €1.13 billion as of January 9, 2026. Its market cap has increased by 130.67% in one year.
Market Cap
1.13B
Enterprise Value
1.27B
Revenue
226.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.84
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from 256.47M to 1.13B, an increase of 341.06%. That is a compound annual growth rate of 41.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.13B | 1.97% |
| Dec 31, 2025 | 1.11B | 127.25% |
| Dec 31, 2024 | 488.15M | 66.23% |
| Dec 29, 2023 | 293.66M | 73.53% |
| Dec 30, 2022 | 169.23M | -47.33% |
| Dec 31, 2021 | 321.29M | 25.28% |
| Oct 6, 2021 | 256.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |